BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protein naturally found in human gastric juice. It is widely studied in preclinical research for its role in tissue repair, angiogenesis, and cytoprotective signalling.

How do I reconstitute BPC-157?

Reconstitute with 1-2 ml of bacteriostatic water. Allow the vial to reach room temperature, inject solvent gently down the inside wall, and swirl gently. Never shake. Store reconstituted solution at 2-8°C and use within 4-6 weeks.

What purity is BioLab's BPC-157?

Every batch is independently tested via HPLC and mass spectrometry to confirm 99%+ purity and correct molecular identity. A batch-specific Certificate of Analysis is available with every order.

How should I store BPC-157?

Store lyophilised vials at -20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 4-6 weeks. Avoid repeated freeze-thaw cycles.

KPV 150 mcg, 60 caps

£45.00

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte stimulating hormone (alpha-MSH) studied for potent anti-inflammatory activity. Research suggests it modulates NF-kB signalling and inflammatory cytokine expression. Available to buy in the UK – 150 mcg x 60 capsules, 99%+ purity.

Purity: ≥99% (HPLC & MS verified)
Quantity: 150 mcg per capsule, 60 capsules
Sequence: Lys-Pro-Val (tripeptide)
Form: Oral capsules
Storage: Room temperature, away from moisture and light

Categories: All Peptides, Immune Support

Description
Reviews (0)

KPV 150 mcg Capsules – Anti-Inflammatory Tripeptide

KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte stimulating hormone (alpha-MSH), the same parent molecule from which Melanotan 2 and PT-141 are derived. However, unlike its parent peptide, KPV retains potent anti-inflammatory activity while lacking melanotropic (skin-darkening) effects.

Research Background

NF-kB pathway modulation – KPV’s primary studied mechanism involves inhibition of the NF-kB (nuclear factor kappa-B) signalling pathway, a master regulator of inflammatory gene expression. By modulating NF-kB nuclear translocation, KPV reduces production of pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6.

Gastrointestinal research – KPV has attracted particular interest in IBD and intestinal inflammation models, where it has been studied for effects on colonic inflammation, mucosal healing, and epithelial barrier integrity. Its oral bioavailability makes it uniquely suited for GI tract research.

Antimicrobial activity – Some studies report direct antimicrobial effects against certain bacterial species, adding another dimension to its GI research profile.

Related Products

Also available as KPV Spray. For complementary immune and gut research, see Larazotide Acetate (gut permeability), LL-37 (antimicrobial), and BPC-157 (GI cytoprotection). Browse Immune Support.